Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
12.18
-0.06 (-0.49%)
Sep 12, 2025, 3:04 PM EDT
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.87 billion as of September 12, 2025. Its market cap has decreased by -9.59% in one year.
Market Cap
2.87B
Enterprise Value
2.63B
Revenue
1.02B
Ranking
n/a
PE Ratio
12.83
Stock Price
$12.18
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.87B, an increase of 42,275.13%. That is a compound annual growth rate of 25.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.87B | 38.84% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | 1.80B | 116.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.52M |